Cargando…

Early Lyme Borreliosis in Patients Treated with Tumour Necrosis Factor-Alfa Inhibitors

The study evaluated the course and outcome of erythema migrans in patients receiving tumour necrosis factor-alpha (TNF-α) inhibitors. Among 4157 adults diagnosed with erythema migrans in the period 2009–2018, 16 (2.6%) patients were receiving TNF-α inhibitors (adalimumab, infliximab, etarnecept, gol...

Descripción completa

Detalles Bibliográficos
Autores principales: Maraspin, Vera, Bogovič, Petra, Rojko, Tereza, Ogrinc, Katarina, Ružić-Sabljić, Eva, Strle, Franc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912410/
https://www.ncbi.nlm.nih.gov/pubmed/31684103
http://dx.doi.org/10.3390/jcm8111857

Ejemplares similares